# Editorial Decision Letter and Revision Roadmap — independent panel, round 1

Synthesizer: editorial_synthesizer_agent protocol (orchestrating session). Contract reviewer/reviewer_full/v2.
Inputs: EIC/R1/R2/R3/DA Phase 1 + Phase 2 files in this folder (five independent subagents, separate contexts,
no access to each other's outputs or to the earlier in-context panel). Provenance: 07_panel_provenance.json.
Conformance (scripts/check_phase_conformance.py): R3 PASS as written. EIC, R1, R2, DA failed only on the Phase 1
terminal tag, because the dispatcher (orchestrating session) instructed `[PRE-COMMITMENT-ACKNOWLEDGED]` instead of
`[CONTRACT-ACKNOWLEDGED]`; with the tag normalized in copies (conformance/*.normalized.md), EIC, R1 and R2 PASS.
DA additionally fails DA-TABLE-PARSE (a Minor-issues table precedes the CRITICAL/MAJOR bands); its content is used
as written. These are dispatcher/format deviations, recorded in the ledger (Iter 5), not substantive defects.

## Per-dimension matrix
| Dim | Priority | Eligible seats: judgement | Verdict |
|---|---|---|---|
| D1 methodology_rigor | mandatory | R1: block (repairable) | block |
| D2 domain_accuracy | mandatory | R2: block (repairable) | block |
| D3 argumentative_coherence | mandatory | DA: block (repairable); R1: warn | block (owner DA) |
| D4 cross_disciplinary_relevance | high | R3: warn | warn |
| D5 writing_and_structure | normal | EIC: warn | warn |
| D6 venue_fit_and_contribution | mandatory | EIC: block (repairable) | block |

F1: no fatal. **F2 fires** (mandatory blocks on D1, D2, D3, D6) → major_revision. F3, F5 also fire (lower
severity). **Decision: MAJOR REVISION.** All five seats signalled Major Revision.

## DA CRITICAL adjudication (visible, per Iron Rule)
C1 "not after does not follow; reversal counterfactual ignored" — **VALIDATED (repairable).** Corroborated by R1-W2,
R1-W3 and EIC-W1. It does not trigger an Accept conflict (decision is Major). Required response: sensitivity bounds,
a reversal-aware comparison, and a conditional title/abstract.

## Consensus themes (≥ 3 seats)
1. The post-coverage null is conditional on parallel trends that the paper's own pre-trends question (R1, DA, EIC).
2. The treatment date (first fiscal year with an LSEG score) likely precedes publication (R1, R2, DA, EIC).
3. "First ESG score" overstates the construct: other ratings existed, including FTSE Russell in Malaysia (R2, R3, DA).
4. The selection mechanism (index membership, disclosure mandates) is unexamined (R2, R3, EIC, DA).
5. Overstated title/abstract/implications (EIC, R3, DA).

## Revision Roadmap (immutable; source-ordered)
| ID | Sources | Sev. | Item |
|---|---|---|---|
| RR-1 | R1-W1, R2-W1, DA-M4, EIC-W1 | major | Publication lag: re-date treatment one year later (R10); report post-publication average; describe treatment as first fiscal year with an LSEG score |
| RR-2 | R1-W2, DA-C1, EIC-W1 | major | Relative-magnitude sensitivity bounds and breakdown value; state that exact HonestDiD sets are not computed |
| RR-3 | R1-W3, DA-C1 | major | Discuss mean-reversion counterfactual; use pre-growth-conditioned comparison (R8) as reversal-aware check |
| RR-4 | R1-W4, EIC-W2, DA-M1 | major | Separate "valuation" (MTB) from "size" (market cap); no returns or shares data (limitation) |
| RR-5 | R1-W5 | major | Balanced cohorts (R11); describe aggregation weights exactly |
| RR-6 | R1-W6, DA-m2, R3-W3 | major | Market-level waves: per-market estimates (IA), market composition in text; cluster-bootstrap caveat |
| RR-7 | R2-W2, R3-W2, DA-M4 | major | Treatment = first LSEG score; other ratings (FTSE Russell/Bursa, SET) not observed; retitle |
| RR-8 | R2-W3, EIC-W3 | major | Correct positioning (Bikmetova & Pirinsky intensive margin + ownership; Tsang et al. 2025; non-U.S. work) |
| RR-9 | R2-W4, R3-W1, EIC-W4, DA-M2 | major | Coverage rule: index membership and disclosure mandates (verified facts only); index entry unobserved |
| RR-10 | EIC-W1, R3-W6, DA-C1 | major | Conditional title, abstract, conclusion; practical advice limited (EIC-W12, DA-M5, R3-W4) |
| RR-11 | R1-W7 | minor | Describe TWFE benchmark (no covariates, all event years) |
| RR-12 | R1-W8 | minor | MDE vs CI wording |
| RR-13 | R1-W9, DA-M3, EIC-W5 | minor | Placebo wording; registered vs exploratory; provide pre-analysis plan |
| RR-14 | R1-W10 | minor | Observation counts and attrition (IA) |
| RR-15 | R1-W11 | minor | R4 described as lower bound only |
| RR-16 | R1-W12, EIC-W8 | minor | Data/code availability and statements in the submitted manuscript |
| RR-17 | R1-W13 | minor | Data errors and pooled winsorization as limitation |
| RR-18 | R1-W14, EIC-W10 | minor | Consistent significance stars |
| RR-19 | R2-W5 | minor | Correct Tsang et al. (2024) author names |
| RR-20 | R2-W6, R2-W8 | minor | Recast comparisons (Kelly & Ljungqvist; Hartzmark & Sussman); analyst initiation analogue; temporary vs permanent index effects |
| RR-21 | R2-W7 | minor | Data vintage, score field, non-definitive recent scores |
| RR-22 | R2-W9 | minor | Rating demand/disagreement/size-bias literature (compact) |
| RR-23 | R3-W5, DA-m4 | minor | Investor-recognition explanation labelled as untested |
| RR-24 | EIC-W7, DA-m5 | minor | Remove "first round of review" remark |
| RR-25 | EIC-W9 | minor | Companion study named in the submitted (single-anonymized) version |
| RR-26 | EIC-W11, DA-m3 | minor | Figure 1 note stands alone; report e = 4 |

Author adjudication (auto-resolved per CLAUDE.md §1b): will_address RR-1…RR-26; items that need data we do not
have (returns, shares outstanding, index membership, prior ratings from other providers, publication dates,
foreign ownership) are addressed as explicit limitations, never with invented data (FORCE RULE B3).
